AuPS Logo Programme
Contents
Previous Next PDF

Digoxin and exercise effects on Na+,K+-pump activity, content, isoform gene and protein expression in human skeletal muscle

X. Gong1, A. Petersen1, S. Sostaric1, C. Goodman1, D. Cameron-Smith2, R. Snow2, K. Murphy1, K. Carey2, J. Aw3, H. Krum3 and M. McKenna1, 1School of Human Movement, Recreation and Performance, Centre for Ageing, Rehabilitation, Exercise and Sport, Victoria University, Melbourne, VIC 8001, Australia, 2School of Exercise Science and Nutrition, Deakin University, Melbourne, VIC 3125, Australia and 3Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC, Australia.

Digoxin is a specific inhibitor of the Na+,K+-pump and is used to treat patients with severe heart failure. In these patients, digoxin binds and blocks ∼13% of Na+,K+-pumps in skeletal muscle and exacerbates muscle K+ loss during exercise. Furthermore in heart failure patients there is no compensatory upregulation of Na+,K+-pump with chronic digitalisation. We have shown that exercise impairs Na+,K+-pump activity, whilst in isolated rat muscles, Na+,K+-pump inhibition leads to early muscle fatigue (Clausen, 2003). Hence, Na+,K+-pump function is likely to be important for skeletal muscle performance. However, the effects of digoxin on Na+,K+-pump content, activity, protein abundance or isoform expression in skeletal muscle of healthy individuals are unknown and were investigated here.

Ten active, but not well-trained healthy volunteers (9 M, 1 F) gave written informed consent. Exercise tests were performed after taking digoxin (DIG, 0.25 mg.d-1) or a placebo (CON) for 14 d, in a randomised, counterbalanced, cross-over, double blind design, with trials separated by 4 weeks. Subjects performed incremental cycle ergometer exercise to measure VO2peak and to determine 33, 67 and 90% VO2peak work rates. On d 14 subjects completed 10 min cycling at each of 33% and 67% VO2peak, then to fatigue at 90% VO2peak. Muscle biopsies taken at rest, after 67%, 90%VO2 peak and 3 h recovery were analysed for Na+,K+-pump content (3H-ouabain binding site), maximal activity (3-O-methyfluorescein phosphatase, 3-O-MFPase), isoform protein abundance and mRNA expression. The Na+, K+-pump isoform (α13, β13) protein contents were measured on muscle extracts, using specific antibodies and western blotting, with isoform mRNA expression determined with real-time RT-PCR analysis.

Serum digoxin was 0.7±0.2 nM at d 13 and 0.8±0.2 nM at d 14 (Mean±SD). Despite this, muscle maximal Na+,K+-pump activity was unchanged by digoxin. However, Na+,K+-pump activity was decreased after exercise, by 13% and 11% at fatigue and 3 h post-exercise, compared to rest, respectively (P<0.05). Furthermore, there was no change in the Na+,K+-pump content with either digoxin or exercise (Rest Digoxin 373±95, Rest Placebo 368±75 pmol.g wet weight-1). No significant change occurred with digoxin for mRNA expression of any of the α1, α2, α3, β1, or β3 isoforms. However, digoxin increased the mRNA expression of the total α mRNA (sum of α1, α2, α3) and the total β mRNA (sum of β1 and β3) at rest by 1.9- and 1.8-fold, respectively (P<0.05), suggesting an effect of digoxin on Na+,K+-pump gene expression. An exercise effect was observed on α3 mRNA expression, being 2.1-and 2.4-fold higher at 3 h post-exercise than during exercise at 67% VO2peak and fatigue, respectively (P<0.05). Similarly, β3 mRNA expression at 3 h post-exercise was increased by 1.8-, 1.4- and 1.6-fold, compared to rest, 67% VO2peak exercise and fatigue, respectively (P<0.05). Digoxin did not alter the protein abundance of any isoform in resting muscle. However, at 3 h post-exercise, the protein abundance was greater with digoxin than in placebo for both α2 and β3 (P<0.05). The β1 protein expression was increased at 3 h post-exercise by 2.2-and 1.5-fold compared to during exercise at 67% VO2peak and fatigue, respectively (P<0.05). Similarly, β3 protein expression was increased at 67% VO2peak and 3 h post-exercise compared to rest, by 1.5-and 1.6-fold, respectively (P<0.05).

In summary, digoxin treatment had only minimal effects on muscle Na+,K+-pumps in healthy individuals. Whilst Na+,K+-pump content, activity or isoform protein expression at rest were unchanged, the subunit total mRNA expression was increased with digoxin and a greater post-exercise protein abundance was found with digoxin for α2 and β3. The lack of reduction in pumps with digitalisation in healthy muscles suggests either that pumps were upregulated and/or that digoxin dissociation was increased.

Clausen, T. (2003) Physiolgical Reviews 83, 1269-324.


Funded by NH&MRC